Pacira Biosciences Inc

Small-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$36.43

+0.01 (+0.03%)

As of Nov 7, 10:10 PM ET ·

Analyst Consensus

Buy

Analysts

High

Coverage

Buy 10 67%

Hold 4 27%

Sell 1 7%

Price Target

Analyst Price Target -37.7% upside

Low Target $15.64

Average Target $22.71

High Target $35.67

Current Price $36.43

Current
$36.43

Target
$22.71

$15.64 $22.71 avg $35.67

Scenario Analysis

Bear Case

$15.64

-57.1%

Low target

Base Case

$22.71

-37.7%

Avg target

Bull Case

$35.67

+-2.1%

High target

Risk/Reward

0.0x

Unfavorable

Price in Context

52-Week High

$36.67

-0.6% from high

52-Week Low

$18.80

+93.8% from low

Target vs 52W High

$22.71

-38.1% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	37	86%	$1,330.33	-1.7%
RDY Dr. Reddy's Laboratories	Sell	42	45%	—	+0.0%
JNJ Johnson & Johnson	Buy	30	70%	$299.55	+8.4%
MRK Merck & Co. Inc.	Buy	35	71%	$159.27	+8.5%
PFE Pfizer Inc.	Hold	34	38%	$33.90	+15.3%
BMY Bristol-Myers Squibb Co	Hold	34	41%	$174.50	+180.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	14	93%	$36.26	-46.1%
ZTS Zoetis Inc	Hold	22	41%	$209.87	+164.3%